$Senseonics (SENS.US)$
I saw the news that diabetes can be cured now. does that mean, this stock ate doomed

$Pfizer (PFE.US)$ Following the prediction and strategy on February 2, in the subsequent market progress, the price did not hit the level of 26.2+, but started to rebound at 26.52! However, this one percent error is clearly not luck, but a mistake! Looking back at the 30-minute chart on 12/15/2023, 26.58 was the upper limit of the central range on the 30-minute chart from 12/13 to 12/15, while Murphy actually took 26.23 in actual trading, which is the axis of that range! The trend must be perfect! It is inevitable that there will be the first rebound on the 30-minute level beyond the current upper limit of the range, and then determine in the subsequent trend whether it will extend upwards or consolidate downwards! The upper limit of the consolidating range downwards then serves as a secondary replenishment point, while the axis at 26.23 is the optimal intraday trading point and even a position for adding to positions in swing trading; this depends on individual style and strategy to choose between day trading or swing trading! Missing 26.52 is, of course, not waiting around, but acting with the trend. The level of 27.50 is the axis of the daily chart, and 28.02 is the highest point of the rebound from 26.52, thus establishing the selling range of 27.50 to 28.02! Within this range, Murphy first executed a trade at 27.53, of course, this position was not very precise, overslept and luckily was awakened by a call from a buddy to place a trade with groggy eyes, because without monitoring, couldn't hit the intraday high point, so immediately placed an order at 27.20 for replenishment hoping to make back the difference of not selling near the high point with a low point replenishment trade within the day, but on February 6th, even that day...

$Senseonics (SENS.US)$
anyone knows what date and time SENS announce yheir Q4?

$Pfizer (PFE.US)$ The weekly divergence pattern is starting to show, but there is still a possibility of deceptive lines. After all, it requires at least a daily trend to form a bottom trend! By examining the daily structure recursively, in order to create the weekly divergence pattern, it is necessary to follow a trend where it reaches 31 and then retraces back to 28.9. However, it is evident that there is a divergence between 28.3 and 28.9 at the 30-minute level, indicating a weakening buy/sell force. Therefore, the probability of directly retracing back to 28.9 near 31 on a daily basis is not high. Instead, it is necessary to retrace directly from the current 28.3 to 28.9 back to 27.3 to 26.7 to create a perfect trend before choosing an upward, downward, or sideways trend! If moving downwards, sell a portion from 28.3 to 28.6, set orders to buy back at 27.3 to 26.7, maintaining the same anticipated trading strategy! If the decline is not over, it will continue from the weak rebound at 25.7 up to 27.15 as mentioned earlier, then further decline to establish the lower limit at 24.9; and in the current scenario, if on the 30-minute level, there is a substantial volume to construct the 31-28.9 daily trend again, one should make a firm move near 31, and a retracement to 28.9 will be a more probable trend realization! This could potentially be the establishment of a new central trend, with a weekly bottom divergence and the emergence of large bullish candlesticks! Thus, the trading strategy should focus on repurchasing chips that surged from 28.3 to 28.6 within the new central range! The above is purely a personal trading journal and does not constitute investment advice or opinions! Trading decisions are at your own discretion! Profit and loss are your own responsibility!

$Pfizer (PFE.US)$
I have waited for this moment a long time.  PFE has finally dropped to its 15-year support line.  In a normal environment, it takes a catastrophe for a stock to break this support line.  Even 2020 PFE didn't break it.  PFE is an extremely strong company,  been around for over 100 years, low debt, high cash flow and the best it pays a divided!   So if it pays 5% dividend and it drops 5% from Here I breakeven.
add -  I can't include this here, but check out th...

$Pfizer (PFE.US)$
PFE earnings before open tomorrow.  If earnings or forecast is a major negative surprise, PFE will head down to around $25. If not, PFE will recover very quickly.  I think investors are more focused on the forecast to see how bad the Covid vaccine impacts. 
$SPDR S&P 500 ETF (SPY.US)$

$Pfizer (PFE.US)$
There is more than 20Millions cancer patients and there is more without diagnosed. Annual cost per patient around $42,000 USD. Will a pharmaceutical giants lived off by Covid-19? No, they live off their innovations and biotechnologies. Cancer treatment market are around 700 Billions and keep increasing due to chemical contamination and food safety concerns. right now Pfizer is at the  lowest since 2016. Dimond hands remains and weaks ...